A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC) (Artikel)

Aus Kompetenzportal
Wechseln zu: Navigation, Suche
A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC) (Artikel)
Autor M. Charokopou, B. Heeg, O. Schoeman, Sabrina Müller, M.J. Tempest, S.C. Schlagmuller, Thomas Wilke
In: Value in Health
Ausgabe 16 (7)
ISBN/ISSN:
Erscheinungsjahr 2013
Jahrgang November 2013
Seitenzahl A475
Hyperlink
Review

In Scotland, drug reimbursement is predominantly based on cost-effectiveness in contrast to the corresponding German AMNOG process. The study compares the reimbursement and pricing process in Germany